The toll receptor TLR9 may also play some role as administration of the ligand CpG (which acts through TLR9) reduced infections in neonatal mice by 95% and increased IL-12 and IFN-γ compared to controls (Barrier et al., 2006). This evidence concerns the gene TLR9 and infection.